Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Berger

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 28, 2011
The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinomaTimothy N Showalter, Tingting Zhan, P Rani Anne, et al.
Pigment Cell & Melanoma Research|May 8, 2019
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated mannerDan A Erkes, Conroy O Field, Claudia Capparelli, et al.
Journal of the American College of Surgeons|July 2, 2013
Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinomaM Mura Assifi, Sarah Zhang, Benjamin E Leiby, et al.
Journal of the American College of Surgeons|May 8, 2007
Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team buildingEugene P Kennedy, Ernest L Rosato, Patricia K Sauter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704Adam C Berger, Miguel Garcia, John P Hoffman, et al.
Journal of the American College of Surgeons|December 21, 2020
Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In SituMarissa Howard-McNatt, Elisabeth Dupont, Theodore Tsangaris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trialAdam C Berger, Kathryn Winter, John P Hoffman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 11, 2012
Serum blood urea nitrogen and serum albumin on the first postoperative day predict pancreatic fistula and major complications after pancreaticoduodenectomyDaniel M Relles, Nathan G Richards, Jordan P Bloom, et al.
Cancer Research|August 18, 2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS MelanomaClaudia Capparelli, Timothy J Purwin, Shea A Heilman, et al.
Journal of the American College of Surgeons|October 23, 2023
Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical TrialLena M Turkheimer, Gina R Petroni, Adam C Berger, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|April 28, 2011
The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinomaTimothy N Showalter, Tingting Zhan, P Rani Anne, et al.
Pigment Cell & Melanoma Research|May 8, 2019
The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated mannerDan A Erkes, Conroy O Field, Claudia Capparelli, et al.
Journal of the American College of Surgeons|July 2, 2013
Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinomaM Mura Assifi, Sarah Zhang, Benjamin E Leiby, et al.
Journal of the American College of Surgeons|May 8, 2007
Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team buildingEugene P Kennedy, Ernest L Rosato, Patricia K Sauter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704Adam C Berger, Miguel Garcia, John P Hoffman, et al.
Journal of the American College of Surgeons|December 21, 2020
Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In SituMarissa Howard-McNatt, Elisabeth Dupont, Theodore Tsangaris, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trialAdam C Berger, Kathryn Winter, John P Hoffman, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 11, 2012
Serum blood urea nitrogen and serum albumin on the first postoperative day predict pancreatic fistula and major complications after pancreaticoduodenectomyDaniel M Relles, Nathan G Richards, Jordan P Bloom, et al.
Cancer Research|August 18, 2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS MelanomaClaudia Capparelli, Timothy J Purwin, Shea A Heilman, et al.
Journal of the American College of Surgeons|October 23, 2023
Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical TrialLena M Turkheimer, Gina R Petroni, Adam C Berger, et al.
Pageof 14